0001437749-23-032461.txt : 20231117 0001437749-23-032461.hdr.sgml : 20231117 20231117160139 ACCESSION NUMBER: 0001437749-23-032461 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231115 FILED AS OF DATE: 20231117 DATE AS OF CHANGE: 20231117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEAVER GREGORY L CENTRAL INDEX KEY: 0001251779 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 231418499 MAIL ADDRESS: STREET 1: 185 BERRY STREET STREET 2: SUITE 6504 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: ATOSSA GENETICS INC DATE OF NAME CHANGE: 20100325 4 1 rdgdoc.xml FORM 4 X0508 4 2023-11-15 0001488039 ATOSSA THERAPEUTICS, INC. ATOS 0001251779 WEAVER GREGORY L C/O ATOSSA THERAPEUTICS, INC., 107 SPRING STREET SEATTLE WA 98104 1 1 Former EVP, CFO, & Director 0 Common Stock 2023-11-15 4 S 0 50000 0.65 D 55 D /s/ Gregory L. Weaver 2023-11-17